A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
研究单位：[1]Eli Lilly and Company[2]AllerVie Clinical Research,Birmingham,Alabama,United States,35209[3]University of Alabama at Birmingham,Birmingham,Alabama,United States,35233[4]Keck Medicine of USC,Arcadia,California,United States,91007[5]University of California, Irvine,Irvine,California,United States,92697[6]DaVinci Research LLC,Roseville,California,United States,95661[7]Colorado ENT & Allergy,Colorado Springs,Colorado,United States,80923[8]Orlando ENT & Allergy,Orlando,Florida,United States,32825[9]NuLine Clinical Trial Center,Pompano Beach,Florida,United States,33060[10]University of South Florida,Tampa,Florida,United States,33613[11]Treasure Valley Medical Research,Boise,Idaho,United States,83706[12]Chicago ENT,Chicago,Illinois,United States,60657[13]South Louisiana Ear, Nose, Throat & Facial Plastic Surgery - PPDS,Mandeville,Louisiana,United States,70471[14]Chesapeake Clinical Research, Inc.,White Marsh,Maryland,United States,21162[15]Brigham and Women's Hospital,Boston,Massachusetts,United States,02215[16]University of Missouri,Columbia,Missouri,United States,65212[17]Washington University School of Medicine,Saint Louis,Missouri,United States,63141[18]Madison ENT & Facial Plastic Surgery,New York,New York,United States,10016[19]UCMC,Cincinnati,Ohio,United States,45267[20]Specialty Physician Associates,Bethlehem,Pennsylvania,United States,18017[21]Medical University of South Carolina- Department of Otolaryngology and Head and Neck Surgery,Charleston,South Carolina,United States,29425[22]UT Southwestern Medical Center,Dallas,Texas,United States,75390-9035[23]University of Texas Physicians Department of Otorhinolaryngology Clinc,Houston,Texas,United States,77030[24]Ear Nose and Throat Associates of Texas PA,McKinney,Texas,United States,75070-5735[25]Alamo ENT Associates,San Antonio,Texas,United States,78258-3227[26]Eastern Virginia Medical School,Norfolk,Virginia,United States,23507[27]Richmond Ear Nose and Throat,Richmond,Virginia,United States,23235[28]The Medical College of Wisconsin,Milwaukee,Wisconsin,United States,53226-3548[29]UZ Gent,Gent,Oost-Vlaanderen,Belgium,9000[30]Pneumocare,Erpent,Belgium,5101[31]Cliniques Universitaires Saint-Luc Avenue Hippocrate 10,Sint-Lambrechts-Woluwe,Belgium,1200[32]Multiprofile Hospital For Active Treatment Dr Tota Venkova A,Gabrovo,Bulgaria,1431[33]Medical Center Medconsult Pleven OOD,Pleven,Bulgaria,5800[34]Diagnostic-Consultative Centre Ascendent EOOD,Sofia,Bulgaria,1202[35]Military Medical Academy - Multiprofile Hospital for Active Treatment - Sofia,,Sofia,Bulgaria,1431[36]University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna,Sofia,Bulgaria,1527[37]Multiprofile Hospital for Active treatment Trakia EOOD,Zagora,Bulgaria,1504[38]St. Joseph's Hospital,Ontario,Canada,N6A 4V2[39]CSAC,Québec,Canada[40]The First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui,China,233004[41]Peking University Third Hospital,Beijing,Beijing,China,100191[42]Beijing Hospital,Beijing,Beijing,China,100730[43]The First Affiliated Hospital Of Fujian Medical University,FuZhou,Fujian,China,350000[44]The People's Hospital of Guangxi Zhuang Autonomous Region,Nan Ning,Guang XI,China,530021[45]Hainan General Hospital,Haikou,Hainan,China,570311[46]Renmin Hospital of Wuhan University,Wu Han,Hubei,China,430060[47]Union Hospital Tongji Medical College Huazhong University of Science and Technology,Wuhan,Hubei,China,430022[48]Huai'an First People's Hospital,Huai'an,Jiangsu,China,223300[49]The Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu,China,221006[50]The First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China,330006[51]Shengjing Hospital of China Medical University,Shenyang,Liaoning,China,110004[52]First People's Hospital of Yinchuan,Yinchuan Shi,Ningxia,China,750002[53]The First Hospital of Shanxi Medical University,Taiyuan,Shanxi,China,30001[54]Sichuan Provincial People's Hospital,Chengdu,Sichuan,China,610072[55]Ningbo Medical Center Lihuili Hospital,Ningbo,Zhejiang,China[56]Beijing Tongren Hospital,Beijing,China,100730[57]The Third Xiangya Hospital of Central South University,Changsha City,China,410013[58]The First People's Hospital of Foshan,Foshan,China,528000[59]Shenzhen Second People's Hospital,Guangdong,China
研究目的：
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.
